Head and neck cancer

[1]  I. Bross,et al.  A study of the etiological factors in cancer of the mouth , 1957, Cancer.

[2]  Pelayo Vilar,et al.  Nasopharyngeal Carcinoma , 1966 .

[3]  K. Rothman,et al.  Epidemiology of laryngeal cancer. , 1980, Epidemiologic reviews.

[4]  L. Pickle,et al.  Snuff dipping and oral cancer among women in the southern United States. , 1981, The New England journal of medicine.

[5]  R. Saracci.  The interactions of tobacco smoking and other agents in cancer etiology. , 1987, Epidemiologic reviews.

[6]  D. Winn,et al.  Smoking and drinking in relation to oral and pharyngeal cancer. , 1988, Cancer research.

[7]  F. Berrino,et al.  Cancer of the larynx/hypopharynx, tobacco and alcohol: Iarc international case‐control study in Turin and Varese (Italy), Zaragoza and Navarra (Spain), Geneva (Switzerland) and Calvados (France) , 1988, International journal of cancer.

[8]  R. Weichselbaum,et al.  Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  L J Peters,et al.  Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. , 1990, The New England journal of medicine.

[10]  W. Hong,et al.  Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. , 1991, The New England journal of medicine.

[11]  L. Hutchins,et al.  Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  J. Jacobs,et al.  Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034. , 1992, International journal of radiation oncology, biology, physics.

[13]  S. Schantz,et al.  Hereditary and environmental factors associated with risk and progression of head and neck cancer. , 1992, Otolaryngologic clinics of North America.

[14]  S. Lippman,et al.  Head and Neck Cancer , 1993, Cancer treatment and research.

[15]  J. Grandis,et al.  Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. , 1993, Cancer research.

[16]  G. Browman,et al.  Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. , 1993, The New England journal of medicine.

[17]  A S Garden,et al.  Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial. , 1993, International journal of radiation oncology, biology, physics.

[18]  E. Myers,et al.  Microlaryngoscopic Surgery for T1 Glottic Lesions: A Cost-Effective Option , 1994, The Annals of otology, rhinology, and laryngology.

[19]  A. Paccagnella,et al.  Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo. , 1994, Journal of the National Cancer Institute.

[20]  J. Tabernero,et al.  Randomized trial of neoadjuvant cisplatin and fluorouracil versus carboplatin and fluorouracil in patients with stage IV-M0 head and neck cancer. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  E. Cohen-Jonathan,et al.  Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trial. , 1996, International journal of radiation oncology, biology, physics.

[22]  J. Califano,et al.  11:40 AM: A Genetic Progression Model for Head and Neck Cancer: Implications for Field Cancerization , 1996 .

[23]  L. Collette,et al.  Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. , 1996, Journal of the National Cancer Institute.

[24]  S. Lippman,et al.  Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment , 1996, Nature Medicine.

[25]  W. Foulkes,et al.  Familial risks of squamous cell carcinoma of the head and neck: retrospective case-control study , 1996, BMJ.

[26]  M. Spitz,et al.  Molecular epidemiology and retinoid chemoprevention of head and neck cancer. , 1997, Journal of the National Cancer Institute.

[27]  B. Jeremic,et al.  Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[28]  J. Quivey,et al.  Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma. , 1997, International journal of radiation oncology, biology, physics.

[29]  R. Day,et al.  Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient Survival , 1998 .

[30]  A. Huang,et al.  Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. , 1998, The New England journal of medicine.

[31]  A. Rademaker,et al.  Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: improved disease control and survival. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  S. Schwartz,et al.  Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. , 1998, Journal of the National Cancer Institute.

[33]  G. Pruneri,et al.  Clinical relevance of cyclin D1 protein overexpression in laryngeal squamous cell carcinoma. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  T. Wendt,et al.  Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  R. Day,et al.  Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival. , 1998, Journal of the National Cancer Institute.

[36]  Jay S. Cooper,et al.  A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003 , 1999 .

[37]  J. Pignon,et al.  Meta-analyses in head and neck squamous cell carcinoma. What is the role of chemotherapy? , 1999, Hematology/oncology clinics of North America.

[38]  G. Calais,et al.  Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. , 1999, Journal of the National Cancer Institute.

[39]  E. Vokes,et al.  Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: a prospective examination. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  E. Vokes,et al.  How Do head and neck cancer patients prioritize treatment outcomes before initiating treatment? , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  D. Sidransky,et al.  Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. , 2000, Journal of the National Cancer Institute.

[42]  S. Glaser,et al.  Epstein-barr virus-associated malignancies: epidemiologic patterns and etiologic implications. , 2000, Critical reviews in oncology/hematology.

[43]  J. Mendelsohn.  Blockade of receptors for growth factors: an anticancer therapy--the fourth annual Joseph H Burchenal American Association of Cancer Research Clinical Research Award Lecture. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[44]  E. Vokes,et al.  The use of concurrent chemotherapy and radiotherapy for locoregionally advanced head and neck cancer. , 2000, Seminars in oncology.

[45]  L. Mao.  Can molecular assessment improve classification of head and neck premalignancy? , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[46]  Benjamin D. Smith,et al.  Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[47]  R. Weichselbaum,et al.  Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  J. Bourhis,et al.  Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data , 2000, The Lancet.

[49]  G. Pruneri,et al.  Cyclin D1 expression is predictive of occult metastases in head and neck cancer patients with clinically negative cervical lymph nodes , 2000, Head & neck.

[50]  B. Jeremic,et al.  Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  S. Lippman,et al.  Predicting cancer development in oral leukoplakia: ten years of translational research. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[52]  B. Coche-Déquéant,et al.  Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma , 2000, British Journal of Cancer.

[53]  A. Rademaker,et al.  Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[54]  A. Dietz,et al.  Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy--results of a multicentric randomized German trial in advanced head-and-neck cancer. , 2001, International journal of radiation oncology, biology, physics.

[55]  E. Vokes,et al.  Locally advanced head and neck cancer , 2001, Current treatment options in oncology.

[56]  Taylor Murray,et al.  Cancer Statistics, 2001 , 2001, CA: a cancer journal for clinicians.

[57]  D. Sidransky,et al.  p16(MTS-1/CDKN2/INK4a) in cancer progression. , 2001, Experimental cell research.

[58]  S. Warnakulasuriya.  Areca nut use following migration and its consequences , 2002, Addiction biology.

[59]  Q. Wei,et al.  Genetic susceptibility–molecular epidemiology of head and neck cancer , 2002, Current opinion in oncology.

[60]  L. Warner,et al.  Radiotherapy versus open surgery versus endolaryngeal surgery (with or without laser) for early laryngeal squamous cell cancer. , 2014, The Cochrane database of systematic reviews.

[61]  Karl Münger,et al.  Human papillomavirus immortalization and transformation functions. , 2002, Virus research.

[62]  E. K. Parkinson,et al.  Telomerase inhibition and the future management of head-and-neck cancer. , 2002, The Lancet. Oncology.

[63]  Johan Wennerberg,et al.  Incidence and survival of squamous cell carcinoma of the tongue in Scandinavia, with special reference to young adults , 2002, International journal of cancer.

[64]  K. Ang,et al.  Radiotherapy for cancer of the head and neck: altered fractionation regimens. , 2002, The Lancet. Oncology.

[65]  C. Gwede,et al.  Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[66]  P. Dulguerov,et al.  Quality of life in patients with oropharynx carcinomas: Assessment after accelerated radiotherapy with or without chemotherapy versus radical surgery and postoperative radiotherapy , 2003, Head & neck.

[67]  V. Torri,et al.  Locoregionally advanced carcinoma of the oropharynx: conventional radiotherapy vs. accelerated hyperfractionated radiotherapy vs. concomitant radiotherapy and chemotherapy--a multicenter randomized trial. , 2003, International journal of radiation oncology, biology, physics.

[68]  E. Vokes,et al.  Concurrent chemoradiotherapy for N2 or N3 squamous cell carcinoma of the head and neck from an occult primary. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[69]  J. Ensley,et al.  An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[70]  Iver Petersen,et al.  Is the p53 inactivation frequency in squamous cell carcinomas of the head and neck underestimated? Analysis of p53 exons 2-11 and human papillomavirus 16/18 E6 transcripts in 123 unselected tumor specimens. , 2003, Cancer research.

[71]  Jeffrey N Myers,et al.  Disparity in pathologic and clinical lymph node staging in oral tongue carcinoma , 2003, Cancer.

[72]  S M Bentzen,et al.  Repopulation in radiation oncology: perspectives of clinical research , 2003, International journal of radiation biology.

[73]  A. Argiris,et al.  Epidemiology, staging, and screening of head and neck cancer. , 2003, Cancer treatment and research.

[74]  B. Maciejewski,et al.  Time factor in postoperative radiotherapy: a multivariate locoregional control analysis in 868 patients. , 2003, International journal of radiation oncology, biology, physics.

[75]  R. Weber,et al.  Outcome of salvage total laryngectomy following organ preservation therapy: the Radiation Therapy Oncology Group trial 91-11. , 2003, Archives of otolaryngology--head & neck surgery.

[76]  R. Weber,et al.  Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. , 2003, The New England journal of medicine.

[77]  D. Husband,et al.  The treatment of early laryngeal cancers (T1–T2 N0): surgery or irradiation? , 2004, Head & neck.

[78]  W. Mendenhall,et al.  Management of T1–T2 glottic carcinomas , 2004, Cancer.

[79]  C. Perou,et al.  Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression , 2004 .

[80]  M. Spitz,et al.  Second primary tumors in patients with upper aerodigestive tract cancers: joint effects of smoking and alcohol (United States) , 2003, Cancer Causes & Control.

[81]  G. Calais,et al.  Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[82]  J Smith,et al.  Tobacco and cancer: recent epidemiological evidence. , 2004, Journal of the National Cancer Institute.

[83]  E. Vokes,et al.  The expanding role of systemic therapy in head and neck cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[84]  A. Paccagnella,et al.  Randomized phase III trial of neoadjuvant chemotherapy in head and neck cancer: 10-year follow-up. , 2004, Journal of the National Cancer Institute.

[85]  J. Jacobs,et al.  Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. , 2004, The New England journal of medicine.

[86]  K. Rufibach,et al.  Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[87]  A. Rademaker,et al.  Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[88]  C. Perou,et al.  Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. , 2004, Cancer cell.

[89]  J. Pignon,et al.  Update of MACH-NC (Meta-Analysis of Chemotherapy in Head & Neck Cancer) database focused on concomitant chemoradiotherapy , 2004 .

[90]  J. Pignon,et al.  Update of MACH-NC (Meta-Analysis of Chemotherapy in Head & Neck Cancer) database focused on concomitant chemoradiotherapy. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[91]  E. Vokes,et al.  Competing Causes of Death and Second Primary Tumors in Patients with Locoregionally Advanced Head and Neck Cancer Treated with Chemoradiotherapy , 2004, Clinical Cancer Research.

[92]  E. Vokes,et al.  Neck dissection in the combined‐modality therapy of patients with locoregionally advanced head and neck cancer , 2004, Head & neck.

[93]  R. Ferris,et al.  Elective Neck Dissection and Survival in Patients With Squamous Cell Carcinoma of the Oral Cavity and Oropharynx , 2004, The Laryngoscope.

[94]  J. Wilson,et al.  Cisplatinum and Bleomycin for advanced or recurrent squamous cell carcinoma of the head and neck: a randomised factorial phase III controlled trial , 2004, Cancer Chemotherapy and Pharmacology.

[95]  A. Garden,et al.  Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[96]  L. Dawson,et al.  Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing. , 2004, International journal of radiation oncology, biology, physics.

[97]  Jacques Bernier,et al.  Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. , 2004, The New England journal of medicine.

[98]  R. Ferris,et al.  Decreased Absolute Counts of T Lymphocyte Subsets and Their Relation to Disease in Squamous Cell Carcinoma of the Head and Neck , 2004, Clinical Cancer Research.

[99]  R. Ferris,et al.  Human leukocyte antigen (HLA) class I defects in head and neck cancer , 2005, Immunologic research.

[100]  J. Bernier.  Alteration of radiotherapy fractionation and concurrent chemotherapy: a new frontier in head and neck oncology? , 2005, Nature Clinical Practice Oncology.

[101]  K. Bjordal,et al.  Quality of Life and Head and Neck Cancer: A 5 Year Prospective Study , 2005, The Laryngoscope.

[102]  D. Raben,et al.  New radiation therapy techniques for the treatment of head and neck cancer. , 2005, Otolaryngologic clinics of North America.

[103]  C. Snyderman,et al.  Head and neck malignancy: is PET/CT more accurate than PET or CT alone? , 2005, Radiology.

[104]  T. Godfrey,et al.  Molecular staging of cervical lymph nodes in squamous cell carcinoma of the head and neck. , 2005, Cancer research.

[105]  Napoleone Ferrara,et al.  VEGF as a Therapeutic Target in Cancer , 2005, Oncology.

[106]  G. Thomas,et al.  Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial , 2005, The Lancet.

[107]  B. Schmidt,et al.  Tongue and tonsil carcinoma , 2005, Cancer.

[108]  A. Argiris.  Induction chemotherapy for head and neck cancer: will history repeat itself? , 2005, Journal of the National Comprehensive Cancer Network : JNCCN.

[109]  B. Murphy,et al.  Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[110]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[111]  J. Shah,et al.  TNM Staging of Cancers of the Head and Neck: Striving for Uniformity Among Diversity , 2005, CA: a cancer journal for clinicians.

[112]  J. Carles,et al.  Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[113]  M. van Glabbeke,et al.  Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501) , 2005, Head & neck.

[114]  P. Wust,et al.  Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[115]  S. Franceschi,et al.  Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review , 2005, Cancer Epidemiology Biomarkers & Prevention.

[116]  Joseph A Califano,et al.  Promoter methylation and inactivation of tumour-suppressor genes in oral squamous-cell carcinoma. , 2006, The Lancet. Oncology.

[117]  Suzanne L Wolden,et al.  Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[118]  E. Feuer,et al.  SEER Cancer Statistics Review, 1975-2003 , 2006 .

[119]  P. Brennan,et al.  Occupational exposure and laryngeal and hypopharyngeal cancer risk in central and eastern Europe. , 2006, American journal of epidemiology.

[120]  J. Sterne,et al.  Human papillomavirus and head and neck cancer: a systematic review and meta‐analysis , 2006, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.

[121]  D. Heron,et al.  Frameless Stereotactic Radiosurgery for Recurrent Head and Neck Carcinoma , 2006, Technology in cancer research & treatment.

[122]  V. Budach,et al.  Postoperative concurrent radiochemotherapy versus radiotherapy in high-risk SCCA of the head and neck: Results of the German phase III trial ARO 96-3. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[123]  S. Lippman,et al.  Fenretinide Activity in Retinoid-Resistant Oral Leukoplakia , 2006, Clinical Cancer Research.

[124]  J. Bourhis,et al.  Re-irradiation combined with chemotherapy after salvage surgery in head and neck carcinoma: A randomized trial from the GETTEC and GORTEC groups. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[125]  W. Mendenhall,et al.  Definitive Radiotherapy for Tonsillar Squamous Cell Carcinoma , 2006, American journal of clinical oncology.

[126]  Y. Nishimura,et al.  Analysis of interfractional set-up errors and intrafractional organ motions during IMRT for head and neck tumors to define an appropriate planning target volume (PTV)- and planning organs at risk volume (PRV)-margins. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[127]  A. Shaha,et al.  Tumours of familial origin in the head and neck. , 2006, Oral Oncology.

[128]  P. Brennan,et al.  Evidence for an Important Role of Alcohol- and Aldehyde-Metabolizing Genes in Cancers of the Upper Aerodigestive Tract , 2006, Cancer Epidemiology Biomarkers & Prevention.

[129]  R. Ferris,et al.  Role of Antigen-Processing Machinery in the In Vitro Resistance of Squamous Cell Carcinoma of the Head and Neck Cells to Recognition by CTL1 , 2006, The Journal of Immunology.

[130]  Patrick Kemmeren,et al.  Multiple robust signatures for detecting lymph node metastasis in head and neck cancer. , 2006, Cancer research.

[131]  J. Beck,et al.  Using decision analysis to determine the cost-effectiveness of intensity-modulated radiation therapy in the treatment of intermediate risk prostate cancer. , 2006, International journal of radiation oncology, biology, physics.

[132]  Sandra Nuyts,et al.  Radiation‐induced xerostomia in patients with head and neck cancer , 2006, Cancer.

[133]  G. Paszkiewicz,et al.  Smoking and Smokeless Tobacco-Associated Human Buccal Cell Mutations and Their Association with Oral Cancer—A Review , 2006, Cancer Epidemiology Biomarkers & Prevention.

[134]  L. Mariani,et al.  High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[135]  E. Feuer,et al.  SEER Cancer Statistics Review, 1975-2003, National Cancer Institute. Bethesda, MD, , 2006 .

[136]  25 : Long-Term Survival Results of a Phase III Intergroup Trial (RTOG 95-01) of Surgery Followed by Radiotherapy vs. Radiochemotherapy for Resectable High Risk Squamous Cell Carcinoma of the Head And Neck , 2006 .

[137]  J. Bourhis,et al.  Randomized phase III trial comparing induction chemotherapy using cisplatin (P) fluorouracil (F) with or without docetaxel (T) for organ preservation in hypopharynx and larynx cancer. Preliminary results of GORTEC 2000-01. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[138]  A. Colevas.  Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[139]  G. Lodi,et al.  Interventions for treating oral leukoplakia. , 2006, The Cochrane database of systematic reviews.

[140]  Yu Shyr,et al.  Gene Expression Differences Associated with Human Papillomavirus Status in Head and Neck Squamous Cell Carcinoma , 2006, Clinical Cancer Research.

[141]  Avraham Eisbruch,et al.  Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[142]  T. Yen,et al.  Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[143]  Christopher U. Jones,et al.  Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. , 2006, The New England journal of medicine.

[144]  Brian O'Sullivan,et al.  Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis , 2006, The Lancet.

[145]  T. Pajak,et al.  Long-term results of Intergroup RTOG 91-11: A phase III trial to preserve the larynx-Induction cisplatin/5-FU and radiation therapy versus concurrent cisplatin and radiation therapy versus radiation therapy. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[146]  U. Duvvuri,et al.  Selective Neck Dissection in Patients with Upper Aerodigestive Tract Cancer with Clinically Positive Nodal Disease , 2006, The Annals of otology, rhinology, and laryngology.

[147]  B. Perez-Ordonez,et al.  Molecular biology of squamous cell carcinoma of the head and neck , 2006, Journal of Clinical Pathology.

[148]  H. Eich,et al.  Efficacy of intensified hyperfractionated and accelerated radiotherapy and concurrent chemotherapy with carboplatin and 5-fluorouracil: updated results of a randomized multicentric trial in advanced head-and-neck cancer. , 2006, International journal of radiation oncology, biology, physics.

[149]  C. la Vecchia,et al.  Body size and laryngeal cancer risk. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[150]  K. Ang,et al.  American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[151]  J. Lefebvre.  Laryngeal preservation in head and neck cancer: multidisciplinary approach. , 2006, The Lancet. Oncology.

[152]  A. Garden,et al.  How to reduce radiation-related toxicity in patients with cancer of the head and neck , 2006, Current oncology reports.

[153]  Petra Ambrosch,et al.  Elective and therapeutic selective neck dissection. , 2006, Oral oncology.

[154]  Y. Shioyama,et al.  Multi-institutional analysis of early squamous cell carcinoma of the hypopharynx treated with radical radiotherapy. , 2006, International journal of radiation oncology, biology, physics.

[155]  I. Angelillo,et al.  Association between fruit and vegetable consumption and oral cancer: a meta-analysis of observational studies. , 2006, The American journal of clinical nutrition.

[156]  M. Pepe,et al.  Do erythropoietin receptors on cancer cells explain unexpected clinical findings? , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[157]  S. Piantadosi,et al.  Advances in Brief Genetic Progression Model for Head and Neck Cancer : Implications for Field Cancerization 1 , 2006 .

[158]  A. Jemal,et al.  Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.

[159]  M. Gillison,et al.  Current topics in the epidemiology of oral cavity and oropharyngeal cancers , 2007, Head & neck.

[160]  T. Gorlia,et al.  Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. , 2007, The New England journal of medicine.

[161]  D. Howlett,et al.  "One-stop" clinics in the investigation and diagnosis of head and neck lumps. , 2007, The British journal of oral & maxillofacial surgery.

[162]  M. Karamouzis,et al.  Therapies directed against epidermal growth factor receptor in aerodigestive carcinomas. , 2007, JAMA.

[163]  A. Schueler,et al.  Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[164]  J. Manola,et al.  TP53 mutations and survival in squamous-cell carcinoma of the head and neck. , 2007, The New England journal of medicine.

[165]  B. Jeremic,et al.  Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation. , 2007, International journal of radiation oncology, biology, physics.

[166]  T. Axéll,et al.  Management of oral epithelial dysplasia: a review. , 2007, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[167]  Carole Fakhry,et al.  Case-control study of human papillomavirus and oropharyngeal cancer. , 2007, The New England journal of medicine.

[168]  Incidence of human papillomavirus (HPV)-related head and neck cancers in the U.S. from 1998-2003: Pre-HPV vaccine licensure , 2007 .

[169]  P. Ambrosch.  The role of laser microsurgery in the treatment of laryngeal cancer , 2007, Current opinion in otolaryngology & head and neck surgery.

[170]  Cecelia E Schmalbach,et al.  Occult primary head and neck carcinoma , 2007, Current oncology reports.

[171]  A. Markoe,et al.  Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. , 2007, The New England journal of medicine.

[172]  A. Armour,et al.  A Phase III randomized parallel-group study of gefitinib (IRESSA) versus methotrexate (IMEX) in patients with recurrent squamous cell carcinoma of the head and neck , 2007 .

[173]  W. Kendal,et al.  Suicide and cancer: a gender-comparative study. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[174]  K. Ang,et al.  The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901. , 2007, International journal of radiation oncology, biology, physics.

[175]  N. Hanna.  Randomized Phase III Trial of Low-dose Isotretinoin for Prevention of Second Primary Tumors in Stage I and II Head and Neck Cancer Patients , 2007 .

[176]  N. Hanna.  Phase III Randomized Trial of Cisplatin Plus Placebo Compared With Cisplatin Plus Cetuximab in Metastatic/Recurrent Head and Neck Cancer: An Eastern Cooperative Oncology Group Study , 2007 .

[177]  N. Hanna.  Open-Label, Uncontrolled, Multicenter Phase II Study to Evaluate the Efficacy and Toxicity of Cetuximab As a Single Agent in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Who Failed to Respond to Platinum-Based Therapy , 2008 .